The FDA has accepted the new drug application (NDA) for SH 201, the first palatable oral liquid of the related chemotherapeutic agent, for the treatment of certain forms of leukemia and other cancers
For general use as an emollient in the symptomatic relief of dry skin conditions.
Foundation Medicine, Inc. announced that the FDA approved FoundationOne Liquid CDx, the Company’s comprehensive pan-tumor liquid biopsy test.
The FDA has approved Gammagard Liquid 10% [Immune Globulin Infusion (Human)] as a treatment for Mmultifocal Motor Neuropathy (MMN). This is...
For fast, effective relief from the pain of common mouth ulcers.
Shire plc announces positive topline Phase III results for the SAHARA study, a global, multi-center, randomized, double-blind, placebo-controlled, partial crossover...
Additional analyses from a negative Phase III clinical trial of Gammagard Liquid/Kiovig (intravenous immunoglobulin), from Baxter, in people with mild...